Pharmaceutical compositions including such proteins or protein encoding sequences, antibodies directed against such proteins or polynucleotides capable of altering expression of such proteins may be used to treat diseases in which beneficial effect may be achieved by modulating the activity of activators of proteins and enzymes; while probe sequences or antibodies may be used for diagnosis of such